CA 125 and VAS Pain Score Changes to Diagnose Endometriosis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
To assess the diagnostic accuracy for the noninvasive detection of pelvic endometriosis of
the combination of two simple parameters: modifications of serum CA 125 and VAS pain score
following one dose of GnRH-analog (GnRH-a).